Cargando…
L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy
Purpose: Several studies evidenced the potential of L1CAM as a prognostic marker in endometrial cancer. The aim of this study was to investigate whether L1CAM can predict lymph node metastasis and could therefore be used preoperatively to identify patients with low to high-intermediate risk endometr...
Autores principales: | Zeiter, Deborah, Vlajnic, Tatjana, Schötzau, Andreas, Heinzelmann-Schwarz, Viola, Montavon, Céline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489141/ https://www.ncbi.nlm.nih.gov/pubmed/34659530 http://dx.doi.org/10.7150/jca.59283 |
Ejemplares similares
-
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
por: Tangen, Ingvild L, et al.
Publicado: (2017) -
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma
por: Arciuolo, Damiano, et al.
Publicado: (2022) -
The sL1CAM in sera of patients with endometrial and ovarian cancers
por: Wojciechowski, Michał, et al.
Publicado: (2016) -
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
por: van der Putten, Louis JM, et al.
Publicado: (2016) -
Fibrin-thrombin sealant does not reduce lymphocele formation in patients with inguinofemoral lymphadenectomy for vulvar cancer
por: Saner, Flurina AM, et al.
Publicado: (2019)